Article Corrected
Keating GM. Ranolazine: a review of its use in chronic stable angina pectoris. Drugs 2008; 68 (17): 2483–2503
Correction Made
Page 2487, column 2, section 2.2.1, paragraph 1, lines 14–19: The following sentence, which previously read:
“There was no significant difference between ranolazine IR and atenolol in terms of the time to angina onset or the time to 1mm ST-segment depression, although exercise duration was significantly (p = 0.006) longer with ranolazine IR than with placebo.[32]”
has now been corrected as follows:
“There was no significant difference between ranolazine IR and atenolol in terms of the time to angina onset or the time to 1mm ST-segment depression, although exercise duration was significantly (p = 0.006) longer with ranolazine IR than with atenolol.[32]”
Note
All online versions of this article have been updated to reflect this correction.
Additional information
The original online version for this chapter can be found at http://dx.doi.org/10.2165/0003495-200868170-00006
Rights and permissions
About this article
Cite this article
Keating, G. Erratum to: Ranolazine: a review of its use in chronic stable angina pectoris. Drugs 71, 1332 (2011). https://doi.org/10.2165/11595790-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11595790-000000000-00000